Physician

Amitha Padmanabhuni, MD

According to 2025 Medicare claims, Amitha Padmanabhuni, MD (NPI: 1306008818) practices endocrinology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is MAIN LINE HEALTHCARE (NPI: 1922077643; TIN: 232359401) and primary practice location at 19406-2080. Padmanabhuni is affiliated with the Delaware Valley ACO (ACO ID: A2024) and Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Padmanabhuni's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 1,192 HCPCS/CPT codes, and received $58,991 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,371 prescription claims across 240 beneficiaries totaling $753,482 in drug costs, led by Ozempic (Semaglutide). DME data shows 238 claims. Open Payments data shows 2 records totaling $34. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $22,160 and ending at $58,991. Concurrently, Part D prescription costs have risen steadily, from $24,059 to $753,482. For DME billing, reported payments moved sharply higher in recent years, from $1,307 to $88,153.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	157	328	$22,160
2019	245	585	$39,425
2020	246	413	$31,785
2021	50	80	$8,799
2022	144	342	$33,148
2023	185	681	$42,360
2024	244	1,192	$58,991

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	129	$24,059
2016	62	404	$83,860
2017	16	33	$6,521
2018	98	377	$94,683
2019	156	870	$198,722
2020	172	1,003	$339,652
2021	127	387	$119,909
2022	97	474	$242,970
2023	171	818	$488,640
2024	240	1,371	$753,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$287
2019	35	111	$7,377
2020	38	144	$11,147
2021	15	87	$8,845
2022	N/R	64	$12,168
2023	27	183	$32,788
2024	60	238	$86,122

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	47	62	$132
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	65	65	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	164	262	$94
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	38	67	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	133	170	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	127	7,108	$222,034
Jardiance	Empagliflozin	105	6,734	$126,016
Trulicity	Dulaglutide	33	2,078	$69,060
Januvia	Sitagliptin Phosphate	35	2,490	$45,735
Mounjaro	Tirzepatide	21	1,204	$40,940

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	45	212	$82,904
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	15	15	$2,979
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$239

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$34	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amitha Padmanabhuni, MD?

Tedicare shows public-source Medicare data for Amitha Padmanabhuni, MD (NPI 1306008818), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amitha Padmanabhuni, MD have ACO affiliation data?

Amitha Padmanabhuni, MD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024) and Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Amitha Padmanabhuni, MD?

Amitha Padmanabhuni, MD is linked to MAIN LINE HEALTHCARE (billing NPI 1922077643) in the available physician profile data.

Does Amitha Padmanabhuni, MD have Open Payments data?

Amitha Padmanabhuni, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.